Kathryn Dalton, DO – Identifying Patients At -Risk for Hereditary Cancers

Salepage : Identifying Patients At -Risk for Hereditary Cancers
Archive : Identifying Patients At -Risk for Hereditary Cancers Digital Download
Delivery : Digital Download Immediately

Identifying Patients at Risk for Hereditary Cancers: Tools to Transform Your Practice is the title of the presentation.

Presentation Goals: Participants should comprehend the following ideas related to hereditary cancer risk assessment and patient care by the end of this presentation:

How Cancer Family History (CFHx) can aid in determining optimal screening intervals.
Why stratifying patients based on risk categories can assist you in determining suitable therapy and screening recommendations
How to implement a Hereditary Cancer Risk Assessment (HCRA) methodology at your facility.
What to look for when choosing a hereditary cancer lab.

Dr. Kathryn Dalton, DO is the Medical Director of the Women’s Health Program at Cape Cod Hospital as well as the High Risk Breast Cancer Program at CUDA Women’s Health Center. She works as a General Surgeon at Cape Cod Hospital in Hyannis, Massachusetts. Dr. Dalton’s clinical interests include breast surgery, oncoplastic breast surgery, nipple sparing mastectomy, hidden scar breast surgery, minimally invasive abdominal surgery, dermatology, genetic counseling and testing, surveillance of high risk breast cancer patients, clinical speaker for Myriad Genetics, and member of the clinical advisory board for Counsyl.

Dr. Dalton is on the speaker’s bureau for Myriad Genetics, which may be interpreted as a real or apparent conflict of interest in the context of this presentation.

More from Categories : Medical